{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:35:10Z","timestamp":1769517310595,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 AR059677"],"award-info":[{"award-number":["K23 AR059677"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005293","name":"Harvard School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000905","name":"Commonwealth Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["R01 AR056215"],"award-info":[{"award-number":["R01 AR056215"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["K24 AR055989"],"award-info":[{"award-number":["K24 AR055989"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["P60 AR047782"],"award-info":[{"award-number":["P60 AR047782"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.amjmed.2015.01.013","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T12:52:09Z","timestamp":1422967929000},"page":"653.e7-653.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A\u00a0Cohort Study"],"prefix":"10.1016","volume":"128","author":[{"given":"Seoyoung C.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niteesh","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2015.01.013_bib1","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2015.01.013_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2015.01.013_bib3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2015.01.013_bib4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/acr.22067","article-title":"Clinical and health care use characteristics of patients newly prescribed allopurinol, febuxostat and colchicine for gout","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjmed.2015.01.013_bib5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans","volume":"67","author":"Singh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjmed.2015.01.013_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2015.01.013_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjmed.2015.01.013_bib8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke:\u00a0a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2015.01.013_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjmed.2015.01.013_bib10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjmed.2015.01.013_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CRD.0b013e318229a908","article-title":"Allopurinol as a cardiovascular drug","volume":"19","author":"Kelkar","year":"2011","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.amjmed.2015.01.013_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2012.06.528","article-title":"Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival","volume":"18","author":"Gotsman","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.amjmed.2015.01.013_bib13","unstructured":"Grimaldi-Bensouda L, Alp\u00e9rovitch A, Aubrun E, et\u00a0al. Impact of allopurinol on risk of myocardial infarction. Ann Rheum Dis, in press."},{"key":"10.1016\/j.amjmed.2015.01.013_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2015.01.013_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10157-012-0769-1","article-title":"Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study","volume":"17","author":"Terawaki","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.amjmed.2015.01.013_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2010.03887.x","article-title":"Impact of allopurinol use on urate concentration and cardiovascular outcome","volume":"71","author":"Wei","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2015.01.013_bib17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCHEARTFAILURE.113.000394","article-title":"Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study","volume":"6","author":"Givertz","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjmed.2015.01.013_bib18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archinternmed.2010.198","article-title":"Gout, allopurinol use, and heart failure outcomes","volume":"170","author":"Thanassoulis","year":"2010","journal-title":"Arch Intern Med"},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2015.01.013_bib19","doi-asserted-by":"crossref","first-page":"ii15","DOI":"10.1093\/rheumatology\/kep088","article-title":"Febuxostat: a new treatment for hyperuricaemia in gout","volume":"48","author":"Edwards","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjmed.2015.01.013_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2015.01.013_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pds.2312","article-title":"A\u00a0systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data","volume":"21","author":"Andrade","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2015.01.013_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pds.2313","article-title":"A\u00a0systematic review of validated methods for identifying heart failure using administrative data","volume":"21","author":"Saczynski","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjmed.2015.01.013_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjmed.2015.01.013_bib24","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/pds.1821","article-title":"An algorithm to identify incident myocardial infarction using Medicaid data","volume":"18","author":"Choma","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjmed.2015.01.013_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A\u00a0combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.amjmed.2015.01.013_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2015.01.013_bib27","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/sim.2781","article-title":"The performance of different propensity score methods for estimating marginal odds ratios","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.amjmed.2015.01.013_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"10.1016\/j.amjmed.2015.01.013_bib29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/aje\/kwr001","article-title":"Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples","volume":"173","author":"Rassen","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjmed.2015.01.013_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.amjmed.2015.01.013_bib31","series-title":"Survival Analysis: A Self-Learning Text","article-title":"Evaluating the proportional hazards Assumption","author":"Kleinbaum","year":"2012"},{"key":"10.1016\/j.amjmed.2015.01.013_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2288-12-180","article-title":"Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments","volume":"12","author":"Schneeweiss","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.amjmed.2015.01.013_bib33","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1185\/03007990903017966","article-title":"Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis","volume":"25","author":"Halpern","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjmed.2015.01.013_bib34","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/rheumatology\/ket158","article-title":"Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire","volume":"52","author":"Harrold","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjmed.2015.01.013_bib35","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjmed.2015.01.013_bib36","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2215\/CJN.11451210","article-title":"A\u00a0randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function","volume":"6","author":"Kanbay","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2015.01.013_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07435800.2011.566235","article-title":"Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia","volume":"37","author":"Melendez-Ramirez","year":"2012","journal-title":"Endocr Res"},{"key":"10.1016\/j.amjmed.2015.01.013_bib38","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","article-title":"Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies","volume":"105","author":"Doehner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2015.01.013_bib39","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000144303.24894.1C","article-title":"Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?","volume":"110","author":"Engberding","year":"2004","journal-title":"Circulation"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934315000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934315000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:28:04Z","timestamp":1762079284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934315000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0002934315000868"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2015.01.013","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A\u00a0Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2015.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}